HIKMA PHARMACEUTICALS PLC ANNUAL REPORT 2015 Financial Statements Continued Notes to the Consolidated Financial Statements Continued 25.
Trade and other payables As at 31 December 2015 2014 $m $m Trade payables 139 129 Accrued expenses 122 105 Other payables 15 14 276 248 Other payables mainly include employees provident fund liability of $5 million 31 December 2014: $5 million, which mainly represents the outstanding contributions to the Hikma Pharmaceuticals Ltd Jordan retirement benefit plan, on which the fund receives 5% interest.
Other provisions Other provisions represent the end of service indemnity provisions for employees of certain Hikma Group subsidiaries.
This provision is calculated based on relevant laws in the countries where each Group company operates, in addition to their own policies.
Movements on the provision for end of service indemnity: 2015 2014 $m $m 1 January 25 20 Additions 5 7 Utilisation 2 2 31 December 28 25 27.
Other current liabilities As at 31 December 2015 2014 $m $m Deferred revenue 16 46 Return and free goods provision 49 35 Others 32 28 97 109 The others balance above includes rebate liabilities across the Group.
